Subsequently, Professor Li led Jiang Yuzhu to a specialized workstation.
It was equipped with various experimental apparatus and reagents, obviously integral to the breast cancer research area.
"This is the workstation specifically dedicated to breast cancer research." Professor Li started to introduce, his voice displaying a professional seriousness, "We are developing a new drug here that targets specific types of breast cancer cells, but it is currently in the experimental phase."
Jiang Yuzhu stared at the various reagents and records on the workstation, her eyes revealing concentration: "What is the current progress of the research?"
Professor Li sighed and shook his head: "The treatment of breast cancer is very complex. Our greatest challenge is how to accurately target cancer cells while minimizing the impact on normal cells. Our current drug is still in the early experimental stage and has not entered clinical trials."